Physicians now have access to an even faster and more accurate handheld ultrasound device, with Signostics today unveiling its new “Signos RT” model.
The Signos RT is Signostics’ second generation portable handheld ultrasound device and builds on the cutting-edge technology of the original Signos device by giving users the critical ability to view ultrasound images in real time.
Signostics anticipates the Signos RT will attract widespread interest from medical practitioners, healthcare professionals and veterinarians globally. The product is already available for sale in Australia and Europe, with USA availability for the human market pending 510(k) clearance.
Signostics Chairman Raymond Spencer says development of the Signos RT was made possible by a $1.9 million Early State Commercialisation grant from Commercialisation Australia (awarded in August 2011), which has helped position the company to capture a larger slice of the growing personal ultrasound market currently estimated to be worth around $3 billion globally.
“From humble beginnings, Signostics has already enjoyed tremendous success and is now on the verge of becoming a worldwide leader in fast and affordable point-of-care medical devices,” said Mr Spencer.
“The next-generation Signos RT has the potential to change the future of medicine and allow physicians to see more and do more anywhere at any time.”
Significantly, Signostics has also today announced a key distribution partnership with Konica Minolta Medical & Graphic Inc.
“At Signostics, we have more than just imagination and today we can announce we have signed an agreement with Konica Minolta Medical & Graphic Inc to sell our devices exclusively through Japan, USA, China and India,” said Signostics’ Chief Executive Officer Warren Ortmann.
“We have also received enormous interest from potential distribution partners throughout Europe, South East Asia and our own Australian market who have seen and experienced our prototype device.
“Under the agreement, Signostics will manufacture the Signos RT with the help of our partner suppliers and deliver it exclusively to Konica Minolta Medical & Graphic Inc under their brand, Sonimage P3, to promote and sell via their existing supply channels in both the human and veterinary markets.
“An OEM partnership of this kind will greatly assist our growth and be a real game-changer for Signostics in terms of distribution and international sales.”
The President and CEO of Konica Minolta Medical & Graphic Inc Atsushi Kodama is anticipating an exciting future ahead.
“We are very excited about selling this truly portable and flexible point-of-care imaging tool and incorporating it into our product portfolio,” said Mr Kodama. “Signostics has developed a revolutionary product which we believe will have a significant impact across our global markets.”
South Australian Minister for Manufacturing, Innovation and Trade Tom Kenyon congratulated Signostics on its achievement and praised the company for its commitment to innovation.